Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Big-Box Retailers Take to the City

By Alyssa Oursler, InvestorPlace Contributor
As more people move to cities, Wal-Mart, Target and others are migrating along with the population. Shifting to the cityscape, though, has its own problems.

Summer’s Drought Will Wither Lots of Stocks

By Jonathan Berr, InvestorPlace Contributor
From ConAgra to Kraft to Papa John's, rising dairy prices will hurt a slew of food and dairy companies. The USDA has already cranked up its price estimates.

For Uranium, an Exit From the Doghouse?

By Aaron Levitt, InvestorPlace Contributor
Supplies that are already tight and Japan's restart of two reactors could lead to a rebound in the sector. One company in particular should benefit.

The New Coffee-Can Portfolio: July Update

By Will Ashworth, InvestorPlace Contributor
In April, we created our own tweaked version of Morningstar's extreme buy-and-hold portfolio -- swapping out a few holdings. So, how's it doing? Let's take a look.

Stop Trading When You Lose Control of Your Emotions

By Charles Sizemore, Chief Investment Strategist, The Freeport Society
Getting on Facebook and finding out you hate Zynga is not a reason to trade in either stock, but it's a reason investors make bad choices

Gold, Silver Futures Barely Move, But Bullion Booms

By Angela Nazworth, InvestorPlace Writer
Gold bullion continued to climb Friday, though futures mostly listed. Meanwhile, a number of mining stocks made decent headway.

The Q2 Earnings Season Shooting Gallery

By Tom Taulli, InvestorPlace Contributor
Quick-draw investors have had little patience for disappointing earnings, and have been turning several high-expectation stocks into Swiss cheese.

Starbucks Gets Creamed for Growing — and That Ain’t Right

By Marc Bastow, InvestorPlace Assistant Editor
Starbucks got clobbered Friday amid releasing a slew of disappointing numbers ... but lost in it all is that the coffee giant still is headed in the right direction.

The New York Times: A Sucker’s Rally

By Jonathan Berr, InvestorPlace Contributor
The publisher is off the critical list -- but it's no picture of health. Its latest quarterly report puts a best light on a dim situation. Don't get fooled.

Comparison Shopping 3 Supermarket Stocks

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Kroger, SuperValu or Whole Foods: Which belongs in your cart? One is fresh, one is stale and one is worth buying when it goes on sale.

Amazon Investors Keep the Faith

By Brad Moon, InvestorPlace Contributor
They're still looking past current pain -- in this case the latest quarterly flop -- to future reward, assuming that all its spending now will pay off later.

Markets Rally on Draghi’s Vow: Thursday’s IP Market Recap

By Marc Bastow, InvestorPlace Assistant Editor
An ECB promise to protect the euro started the ball rolling on what turned into a solid, broad-based gain on Wall Street.

Thursday Slow for Gold, Silver Futures; NovaGold Pummeled

By Angela Nazworth, InvestorPlace Writer
Gold eked higher while silver traded mostly flat Thursday. Meanwhile, NovaGold Resources lost more than 25% after a potential joint venture collapsed.

Soft Drink Stocks: 2 Have Fizz; 2 Taste Flat

By Susan J. Aluise, Aviation, Auto & Transportation Writer
When it comes to value, bigger isn't always better. At least not now. Two smaller names that focus on the domestic market look like the right choice.

Sizzling Small Caps: Can They Keep It Up?

By James Brumley, InvestorPlace Feature Writer
Get the scoop on these three small cap picks to find out if they will be able to keep up their hot streaks.

AstraZeneca Tops Earnings Forecasts as Sales Fall

By Christopher Freeburn, InvestorPlace Writer
British pharmaceutical giant AstraZeneca posted second-quarter earnings that topped Wall Street's forecast for earnings, but fell short of revenue projections.

Why Investors Should Bet on Barry Diller

By Jonathan Berr, InvestorPlace Contributor
His InterActiveCorp may be complex and unwieldy, but it's on a roll that should continue. Plus, Diller has plenty of opportunities to buy up other properties.

Sprint Posts Bigger Q2 Loss, Shares Jump

By Christopher Freeburn, InvestorPlace Writer
Sprint posted a larger-than-expected second-quarter loss, but topped revenue estimates and activated 1.5 million iPhones, sending its shares higher.

Natural Gas Finally Shows Some Spark

By Aaron Levitt, InvestorPlace Contributor
Rising demand and falling supplies have prices moving up. It's creating a good opportunity to get into the sector while share prices are still depressed.
Load More Articles